Annual EBITDA
-$39.12 M
+$8.07 M+17.11%
31 December 2023
Summary:
GlycoMimetics annual earnings before interest, taxes, depreciation & amortization is currently -$39.12 million, with the most recent change of +$8.07 million (+17.11%) on 31 December 2023. During the last 3 years, it has risen by +$12.12 million (+23.65%). GLYC annual EBITDA is now -1147.46% below its all-time high of $3.73 million, reached on 31 December 2012.GLYC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$5.71 M
+$4.63 M+44.77%
30 September 2024
Summary:
GlycoMimetics quarterly earnings before interest, taxes, depreciation & amortization is currently -$5.71 million, with the most recent change of +$4.63 million (+44.77%) on 30 September 2024. Over the past year, it has increased by +$4.06 million (+41.53%). GLYC quarterly EBITDA is now -154.76% below its all-time high of $10.43 million, reached on 30 June 2015.GLYC Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$36.73 M
+$4.06 M+9.95%
30 September 2024
Summary:
GlycoMimetics TTM earnings before interest, taxes, depreciation & amortization is currently -$36.73 million, with the most recent change of +$4.06 million (+9.95%) on 30 September 2024. Over the past year, it has increased by +$3.40 million (+8.48%). GLYC TTM EBITDA is now -1949.36% below its all-time high of $1.99 million, reached on 31 March 2013.GLYC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLYC EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.1% | +41.5% | +8.5% |
| 3 y3 years | +23.6% | +66.9% | +40.1% |
| 5 y5 years | +23.6% | +59.3% | +39.5% |
GLYC EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +38.1% | at high | +67.1% | at high | +42.2% |
| 5 y | 5 years | at high | +38.1% | at high | +67.1% | at high | +42.2% |
| alltime | all time | -1147.5% | +38.1% | -154.8% | +67.1% | -1949.4% | +42.2% |
GlycoMimetics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.71 M(-44.8%) | -$36.73 M(-9.9%) |
| June 2024 | - | -$10.35 M(-6.8%) | -$40.78 M(+3.7%) |
| Mar 2024 | - | -$11.10 M(+16.0%) | -$39.33 M(+0.5%) |
| Dec 2023 | -$39.12 M(-17.1%) | -$9.57 M(-2.1%) | -$39.12 M(-2.5%) |
| Sept 2023 | - | -$9.77 M(+10.0%) | -$40.13 M(+2.7%) |
| June 2023 | - | -$8.89 M(-18.5%) | -$39.08 M(-10.1%) |
| Mar 2023 | - | -$10.90 M(+3.0%) | -$43.49 M(-7.8%) |
| Dec 2022 | -$47.20 M(-25.3%) | -$10.58 M(+21.3%) | -$47.20 M(-12.6%) |
| Sept 2022 | - | -$8.72 M(-34.4%) | -$53.98 M(-13.7%) |
| June 2022 | - | -$13.30 M(-8.9%) | -$62.53 M(-1.6%) |
| Mar 2022 | - | -$14.60 M(-15.9%) | -$63.57 M(+0.6%) |
| Dec 2021 | -$63.18 M(+23.3%) | -$17.36 M(+0.6%) | -$63.18 M(+3.0%) |
| Sept 2021 | - | -$17.27 M(+20.5%) | -$61.32 M(+6.3%) |
| June 2021 | - | -$14.34 M(+0.9%) | -$57.71 M(+0.5%) |
| Mar 2021 | - | -$14.21 M(-8.3%) | -$57.41 M(+12.0%) |
| Dec 2020 | -$51.24 M(-16.2%) | -$15.50 M(+13.5%) | -$51.24 M(+0.5%) |
| Sept 2020 | - | -$13.66 M(-2.7%) | -$51.01 M(-0.7%) |
| June 2020 | - | -$14.04 M(+74.6%) | -$51.38 M(-5.0%) |
| Mar 2020 | - | -$8.04 M(-47.3%) | -$54.09 M(-11.5%) |
| Dec 2019 | -$61.11 M(+19.3%) | -$15.27 M(+8.8%) | -$61.11 M(+0.6%) |
| Sept 2019 | - | -$14.04 M(-16.2%) | -$60.73 M(+2.7%) |
| June 2019 | - | -$16.75 M(+11.2%) | -$59.15 M(+8.6%) |
| Mar 2019 | - | -$15.06 M(+1.1%) | -$54.48 M(+6.4%) |
| Dec 2018 | -$51.23 M | -$14.89 M(+19.6%) | -$51.23 M(+11.8%) |
| Sept 2018 | - | -$12.45 M(+3.1%) | -$45.80 M(+10.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$12.08 M(+2.3%) | -$41.47 M(+18.3%) |
| Mar 2018 | - | -$11.81 M(+24.7%) | -$35.04 M(+12.5%) |
| Dec 2017 | -$33.67 M(+6.1%) | -$9.47 M(+16.7%) | -$31.15 M(+3.9%) |
| Sept 2017 | - | -$8.11 M(+43.4%) | -$29.99 M(+0.9%) |
| June 2017 | - | -$5.66 M(-28.6%) | -$29.72 M(-7.4%) |
| Mar 2017 | - | -$7.92 M(-4.7%) | -$32.11 M(+1.2%) |
| Dec 2016 | -$31.72 M(+151.9%) | -$8.31 M(+6.0%) | -$31.72 M(-1.6%) |
| Sept 2016 | - | -$7.84 M(-2.6%) | -$32.25 M(+2.3%) |
| June 2016 | - | -$8.05 M(+6.9%) | -$31.53 M(+141.6%) |
| Mar 2016 | - | -$7.53 M(-14.8%) | -$13.05 M(+3.6%) |
| Dec 2015 | -$12.59 M(+14.7%) | -$8.84 M(+24.1%) | -$12.59 M(+13.4%) |
| Sept 2015 | - | -$7.12 M(-168.2%) | -$11.11 M(+4.3%) |
| June 2015 | - | $10.43 M(-247.6%) | -$10.65 M(-18.0%) |
| Mar 2015 | - | -$7.07 M(-3.9%) | -$12.98 M(+18.2%) |
| Dec 2014 | -$10.98 M(+4.8%) | -$7.35 M(+10.4%) | -$10.98 M(+47.2%) |
| Sept 2014 | - | -$6.66 M(-182.2%) | -$7.46 M(+66.9%) |
| June 2014 | - | $8.10 M(-259.8%) | -$4.47 M(-72.1%) |
| Mar 2014 | - | -$5.07 M(+32.3%) | -$16.04 M(+53.1%) |
| Dec 2013 | -$10.47 M(-380.4%) | -$3.83 M(+4.5%) | -$10.47 M(+74.7%) |
| Sept 2013 | - | -$3.67 M(+5.9%) | -$6.00 M(+305.6%) |
| June 2013 | - | -$3.46 M(-806.1%) | -$1.48 M(-174.4%) |
| Mar 2013 | - | $490.60 K(-23.8%) | $1.99 M(+32.8%) |
| Dec 2012 | $3.73 M(-162.2%) | $644.10 K(-24.3%) | $1.50 M(+75.7%) |
| Sept 2012 | - | $851.20 K | $851.20 K |
| Dec 2011 | -$6.00 M | - | - |
FAQ
- What is GlycoMimetics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for GlycoMimetics?
- What is GlycoMimetics annual EBITDA year-on-year change?
- What is GlycoMimetics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for GlycoMimetics?
- What is GlycoMimetics quarterly EBITDA year-on-year change?
- What is GlycoMimetics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for GlycoMimetics?
- What is GlycoMimetics TTM EBITDA year-on-year change?
What is GlycoMimetics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of GLYC is -$39.12 M
What is the all time high annual EBITDA for GlycoMimetics?
GlycoMimetics all-time high annual earnings before interest, taxes, depreciation & amortization is $3.73 M
What is GlycoMimetics annual EBITDA year-on-year change?
Over the past year, GLYC annual earnings before interest, taxes, depreciation & amortization has changed by +$8.07 M (+17.11%)
What is GlycoMimetics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of GLYC is -$5.71 M
What is the all time high quarterly EBITDA for GlycoMimetics?
GlycoMimetics all-time high quarterly earnings before interest, taxes, depreciation & amortization is $10.43 M
What is GlycoMimetics quarterly EBITDA year-on-year change?
Over the past year, GLYC quarterly earnings before interest, taxes, depreciation & amortization has changed by +$4.06 M (+41.53%)
What is GlycoMimetics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of GLYC is -$36.73 M
What is the all time high TTM EBITDA for GlycoMimetics?
GlycoMimetics all-time high TTM earnings before interest, taxes, depreciation & amortization is $1.99 M
What is GlycoMimetics TTM EBITDA year-on-year change?
Over the past year, GLYC TTM earnings before interest, taxes, depreciation & amortization has changed by +$3.40 M (+8.48%)